Chim CS - Search Results

1

SMILE for natural killer/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study Group.

Kwong YL, Kim WS, Lim ST, Kim SJ, Tang T, Tse E, Leung AY, Chim CS. Kwong YL, et al. Among authors: chim cs. Blood. 2012 Oct 11;120(15):2973-80. doi: 10.1182/blood-2012-05-431460. Epub 2012 Aug 23. Blood. 2012. PMID: 22919026 Free article.

2

Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index.

Chim CS, Ma SY, Au WY, Choy C, Lie AK, Liang R, Yau CC, Kwong YL. Chim CS, et al. Blood. 2004 Jan 1;103(1):216-21. doi: 10.1182/blood-2003-05-1401. Epub 2003 Aug 21. Blood. 2004. PMID: 12933580 Free article.

3

SOCS1 and SHP1 hypermethylation in multiple myeloma: implications for epigenetic activation of the Jak/STAT pathway.

Chim CS, Fung TK, Cheung WC, Liang R, Kwong YL. Chim CS, et al. Blood. 2004 Jun 15;103(12):4630-5. doi: 10.1182/blood-2003-06-2007. Epub 2004 Feb 19. Blood. 2004. PMID: 14976049 Free article.

4

Fludarabine, mitoxantrone and dexamethasone in the treatment of indolent B- and T-cell lymphoid malignancies in Chinese patients.

Ma SY, Au WY, Chim CS, Lie AK, Lam CC, Tse E, Leung AY, Liang R, Kwong YL. Ma SY, et al. Among authors: chim cs. Br J Haematol. 2004 Mar;124(6):754-61. doi: 10.1111/j.1365-2141.2004.04852.x. Br J Haematol. 2004. PMID: 15009063 Free article. Clinical Trial.

5

Quantification of circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patients.

Au WY, Pang A, Choy C, Chim CS, Kwong YL. Au WY, et al. Among authors: chim cs. Blood. 2004 Jul 1;104(1):243-9. doi: 10.1182/blood-2003-12-4197. Epub 2004 Mar 18. Blood. 2004. PMID: 15031209 Free article.

6

Effectiveness of prophylactic Anti-HBV therapy in allogeneic hematopoietic stem cell transplantation with HBsAg positive donors.

Hui CK, Lie A, Au WY, Ma SY, Leung YH, Zhang HY, Sun J, Cheung WW, Chim CS, Kwong YL, Liang R, Lau GK. Hui CK, et al. Among authors: chim cs. Am J Transplant. 2005 Jun;5(6):1437-45. doi: 10.1111/j.1600-6143.2005.00887.x. Am J Transplant. 2005. PMID: 15888052 Free article.

7

Alemtuzumab induced complete remission of therapy-resistant pure red cell aplasia.

Au WY, Lam CC, Chim CS, Pang AW, Kwong YL. Au WY, et al. Among authors: chim cs. Leuk Res. 2005 Oct;29(10):1213-5. doi: 10.1016/j.leukres.2005.02.018. Epub 2005 Apr 25. Leuk Res. 2005. PMID: 16111536

8

Long-term outcome of 231 patients with essential thrombocythemia: prognostic factors for thrombosis, bleeding, myelofibrosis, and leukemia.

Chim CS, Kwong YL, Lie AK, Ma SK, Chan CC, Wong LG, Kho BC, Lee HK, Sim JP, Chan CH, Chan JC, Yeung YM, Law M, Liang R. Chim CS, et al. Arch Intern Med. 2005 Dec 12-26;165(22):2651-8. doi: 10.1001/archinte.165.22.2651. Arch Intern Med. 2005. PMID: 16344424

9

Serial studies of methylation of CDKN2B and CDKN2A in relapsed acute promyelocytic leukaemia treated with arsenic trioxide.

Au WY, Fung AT, Ma ES, Chan CH, Wong KF, Chim CS, Liang RH, Kwong YL. Au WY, et al. Among authors: chim cs. Br J Haematol. 2005 Dec;131(5):632-5. doi: 10.1111/j.1365-2141.2005.05818.x. Br J Haematol. 2005. PMID: 16351640 Free article.

10

Adverse prognostic impact of CDKN2B hyper-methylation in acute promyelocytic leukemia.

Chim CS, Kwong YL. Chim CS, et al. Leuk Lymphoma. 2006 May;47(5):815-25. doi: 10.1080/10428190500513827. Leuk Lymphoma. 2006. PMID: 16753865 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

264 results

Search Page

Filters